170 related articles for article (PubMed ID: 12413779)
1. Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study.
Li G; Hu Y; Yang W; Jiang Y; Wang J; Xiao J; Hu Z; Pan X; Howard BV; Bennett PH;
Diabetes Res Clin Pract; 2002 Dec; 58(3):193-200. PubMed ID: 12413779
[TBL] [Abstract][Full Text] [Related]
2. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
[TBL] [Abstract][Full Text] [Related]
3. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
4. [Model of development of diabetes mellitus in adult Chinese].
Li G; Wang J; Chen C
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):914-7. PubMed ID: 11702665
[TBL] [Abstract][Full Text] [Related]
5. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
[TBL] [Abstract][Full Text] [Related]
6. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
[TBL] [Abstract][Full Text] [Related]
7. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
Salinitri FD; Pinelli NR; Martin ET; Jaber LA
Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.
Weyer C; Tataranni PA; Bogardus C; Pratley RE
Diabetes Care; 2001 Jan; 24(1):89-94. PubMed ID: 11194248
[TBL] [Abstract][Full Text] [Related]
10. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study.
Gong Q; Zhang P; Wang J; Gregg EW; Cheng YJ; Li G; Bennett PH;
Diabetes Obes Metab; 2021 Oct; 23(10):2385-2394. PubMed ID: 34212465
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
Yoon U; Kwok LL; Magkidis A
Metabolism; 2013 Feb; 62(2):303-14. PubMed ID: 22959500
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes.
Fukushima M; Usami M; Ikeda M; Nakai Y; Taniguchi A; Matsuura T; Suzuki H; Kurose T; Yamada Y; Seino Y
Metabolism; 2004 Jul; 53(7):831-5. PubMed ID: 15254872
[TBL] [Abstract][Full Text] [Related]
14. [The relation between fasting plasma glucose concentrations and insulin resistance].
Li L; Wang GX; Li P; Shang XJ; Liu C; Wang YJ; Yue GY
Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):755-8. PubMed ID: 16255885
[TBL] [Abstract][Full Text] [Related]
15. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
Kitabchi AE; Temprosa M; Knowler WC; Kahn SE; Fowler SE; Haffner SM; Andres R; Saudek C; Edelstein SL; Arakaki R; Murphy MB; Shamoon H;
Diabetes; 2005 Aug; 54(8):2404-14. PubMed ID: 16046308
[TBL] [Abstract][Full Text] [Related]
16. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
[TBL] [Abstract][Full Text] [Related]
17. Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review.
Anwar S; Shikalgar N
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S913-S917. PubMed ID: 28711517
[TBL] [Abstract][Full Text] [Related]
18. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
Henninger J; Hammarstedt A; Rawshani A; Eliasson B
BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
20. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.
Mozaffarian D; Marfisi R; Levantesi G; Silletta MG; Tavazzi L; Tognoni G; Valagussa F; Marchioli R
Lancet; 2007 Aug; 370(9588):667-75. PubMed ID: 17720018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
